Impact of Raloxifene or Tamoxifen Use on Endometrial Cancer Risk: A Population-Based Case-Control Study

PURPOSE: Raloxifene reduces breast cancer risk in women with osteoporosis, and both tamoxifen and raloxifene prevent breast cancer in high-risk women. However, in vitro, raloxifene does not share the pro-estrogenic effects of tamoxifen on the endometrium. Randomized trials of these agents have provi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: DeMichele, Angela, Troxel, Andrea B., Berlin, Jesse A., Weber, Anita L., Bunin, Greta R., Turzo, Elene, Schinnar, Rita, Burgh, Desiree, Berlin, Michelle, Rubin, Stephen C., Rebbeck, Timothy R., Strom, Brian L.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2008
Assuntos:
Gynecologic Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2654370/
https://ncbi.nlm.nih.gov/pubmed/18757329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.14.0921
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados